インフルエンザ診断の世界市場分析:製品別(インスリン注射器、インスリンペン、インスリンポンプ、インスリン注射器)、エンドユーザー別(病院、ホームケア、援助生活センター、養護施設)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Insulin Delivery Devices Market Analysis By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Research Methodology
1.1. Information Procurement
1.2. Data Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Insulin delivery devices: Market dynamics
3.2.1. Market driver analysis
3.2.2. Market restraints analysis
3.3. Key Opportunities Prioritized
3.4. Insulin delivery devices – SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.5. Industry Analysis – Porter’s
3.6. Competitive Landscape: Market Position Analysis
Chapter 4. Market Categorization 1: Product Estimates & Trend Analysis
4.1. Insulin delivery devices: Product Movement Analysis
4.2. Insulin syringes
4.2.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.3. Insulin pens
4.3.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.4. Insulin pumps
4.4.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
4.5. Insulin injectors
4.5.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5. Market Categorization 2: By End-Use, Estimates & Trend Analysis
5.1. Insulin delivery devices: Technology Movement Analysis
5.2. Hospital
5.2.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
5.3. Homecare
5.3.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
5.4. Others
5.4.1. Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6. Market Categorization 5: Regional Estimates & Trend Analysis
6.1. Insulin Delivery Devices Market Share (%) Analysis, by Region 2016 & 2025
6.2. North America
6.2.1. U.S.
6.2.1.1. U.S. insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.2.1.2. U.S. insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.2.2. Canada
6.2.2.1. Canada insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.2.2.2. Canada insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.3. Europe
6.3.1. Germany
6.3.1.1. Germany insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.3.1.2. Germany insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.3.2. UK
6.3.2.1. UK insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.3.2.2. UK insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.4. Asia Pacific
6.4.1. China
6.4.1.1. China insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.4.1.2. China insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.4.2. India
6.4.2.1. India insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.4.2.2. India insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.5. Latin America
6.5.1. Brazil
6.5.1.1. Brazil insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.5.1.2. Brazil insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.5.2. Mexico
6.5.2.1. Mexico insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.5.2.2. Mexico insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.6. MEA
6.6.1. South Africa
6.6.1.1. South Africa insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.6.1.2. South Africa insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia insulin delivery devices market, by product, 2014 – 2025 (USD Million)
6.6.2.2. Saudi Arabia insulin delivery devices market, by end-use, 2014 – 2025 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.2. Novo Nordisk A/S
7.2.1. Company overview
7.2.2. Financial performance
7.2.3. Product benchmarking
7.2.4. Strategic initiatives
7.3. Sanofi
7.3.1. Company overview
7.3.2. Financial performance
7.3.3. Product benchmarking
7.3.4. Strategic initiatives
7.4. Eli Lilly and Company
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Product benchmarking
7.4.4. Strategic initiatives
7.5. Biocon Ltd.
7.5.1. Company overview
7.5.2. Financial performance
7.5.3. Product benchmarking
7.5.4. Strategic initiatives
7.6. Ypsomed AG
7.6.1. Company overview
7.6.2. Financial performance
7.6.3. Product benchmarking
7.6.4. Strategic initiatives
7.7. Wockhardt Ltd.
7.7.1. Company overview
7.7.2. Financial performance
7.7.3. Product benchmarking
7.7.4. Strategic initiatives
7.8. Medtronic
7.8.1. Company overview
7.8.2. Financial performance
7.8.3. Product benchmarking
7.8.4. Strategic initiatives
7.9. Abbott Laboratories
7.9.1. Company overview
7.9.2. Financial performance
7.9.3. Product benchmarking
7.9.4. Strategic initiatives
7.10. F. Hoffmann-La Roche, Ltd.
7.10.1. Company overview
7.10.2. Financial performance
7.10.3. Product benchmarking
7.10.4. Strategic initiatives


【レポート販売概要】

■ タイトル:インフルエンザ診断の世界市場分析:製品別(インスリン注射器、インスリンペン、インスリンポンプ、インスリン注射器)、エンドユーザー別(病院、ホームケア、援助生活センター、養護施設)、セグメント予測、2014-2025
■ 英文:Insulin Delivery Devices Market Analysis By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2014-2025
■ 発行日:2016年11月7日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707439
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。